groups:koenig:start

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
Last revisionBoth sides next revision
groups:koenig:start [2017/03/02 11:33] – email updated koeniggroups:koenig:start [2022/03/25 12:32] koenig
Line 1: Line 1:
-{{:groups:koenig:vln-header-background.jpg?900}} +{{:groups:koenig:banner.png?900|}}
-\\ +
-====== Junior Group Systems Biology of Liver ======+
  
-{{:groups:koenig:koenig_bereich_03.png?500 }} Junior Group Leader\\ +====== Systems Medicine of Liver ====== 
- [[https://www.livermetabolism.com/contact.html|Dr. Matthias König]]+ 
 + 
 +{{:groups:koenig:koenig_500.png?200 }} **[[https://www.livermetabolism.com|Homepage]]**\\ 
 + 
 +**Group Leader**\\ 
 +[[https://www.livermetabolism.com/cv/|Dr. Matthias König]]\\
  
-Institute for Theoretical Biology\\ 
 Humboldt-University Berlin\\ Humboldt-University Berlin\\
-Invalidenstraße 4310117 Berlin, Germany\\ +Institute for BiologyInstitute for Theoretical Biology\\ 
-phone +49 30 2093-8450\\ +Philippstraße 13, 10115 Berlin, Germany\\ 
-[[koenigmx@hu-berlin.de]] +phone +49 30 2093 98435\\ 
-\\ +**[[koenigmx@hu-berlin.de]]**\\
-\\ +
-\\ +
-\\ +
-We are investigating liver metabolism and function with the help of computational models and methods.\\ +
-Read more about the group: [[https://www.livermetabolism.com|www.livermetabolism.com]]\\ +
-[[https://www.livermetabolism.com/|Projects]]\\ +
-[[https://www.livermetabolism.com/publications.html|Publications]]\\ +
-\\ +
-The liver is the central metabolic organ of our body playing a crucial role in the clearance of +
-drugs, xenobiotics and numerous metabolites from the bloodstream. The quantification of these +
-liver functions is essential to assess the status of the liver, obtain information about the degree +
-of impairment, to evaluate treatment response or to select transplant recipients.+
  
-This project will establish a standardized multiscale model framework of the human liver readily 
-adaptable to various quantitative liver function tests currently used in the clinics. The resulting 
-models will be personalized with individual imaging data from CT and PET in combination with 
-anthropomorphic information like gender, age, body weight and height and used for the 
-evaluation of quantitative liver function tests in a personalized context. Within this project three 
-main applications will be realized, respectively represented by a showcase 
-  - normal liver function (galactose) 
-  - detoxification of drugs (drug cocktail, indocyanine green, bromsulphalein) 
-  - impaired liver (cirrhosis & liver disease) 
-\\ 
-{{:groups:koenig:multiscale-galactose.png?nolink |}} 
-\\ 
-\\ 
-| {{:groups:koenig:bmbf.png?nolink |}} | MK is supported by the Federal Ministry of Education and Research (BMBF, Germany) within the research network Systems Medicine of the Liver (LiSyM) (grant number 031L0054). | 
-